Related Experiment Video

Updated: Aug 24, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Vaccines for the prevention of respiratory viral infections: problems and current status

Wieslawa Olszewska1, Rebecca Helson, Peter J M Openshaw

  • 1Department of Respiratory Medicine, Wright Fleming Institute for Infection and Immunity, National Heart and Lung Division, Faculty of Medicine, Imperial College, St. Mary's Campus, Paddington, London W2 1PG, UK. w.olszewska@imperial.ac.uk

Expert Opinion on Investigational Drugs
|June 4, 2004
PubMed

Insights

Developing vaccines for acute respiratory virus infections in infants and the elderly is crucial. This review covers current vaccine development and future strategies for preventing these common illnesses.

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Acute respiratory virus infections are a leading cause of illness and hospitalization in infants and the elderly.
  • Emerging respiratory viruses and pandemic influenza risk necessitate improved preventative measures.
  • Vaccine development for key viruses like RSV, rhinoviruses, and coronaviruses has been slow.

Purpose of the Study:

  • To review the current status of vaccine development for major respiratory viral diseases.
  • To outline novel approaches for future vaccine strategies against respiratory viruses.

Main Methods:

  • Literature review of current vaccine development.
  • Analysis of novel vaccine technologies and strategies.

Main Results:

  • Significant challenges and slow progress in developing vaccines for common respiratory viruses.
  • Identification of promising novel approaches for future vaccine development.

Conclusions:

  • There is an urgent need for effective vaccines against a range of respiratory viruses.
  • Novel strategies are essential to accelerate vaccine development and combat respiratory viral diseases.

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...